Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
LAROTAXEL
Not Marketed
Breast Neoplasms
TCD10037NANCT00387907Summary
LAROTAXEL
Not Marketed
Breast Neoplasms
TCD6511NAEudraCT: 2006-006474-21Summary Results
LAROTAXEL
Not Marketed
Breast Neoplasms
TCD6595NAEudraCT: 2006-001341-34Summary Results
LEFLUNOMIDE
Arava
Arthritis
HWA486_4020OSRANCT00451971Summary
LEFLUNOMIDE
Arava
Arthritis
HWA486_4021NANCT00563849Summary
LEFLUNOMIDE
Arava
Arthritis
HWA486_4022NANCT00280644Summary
LEFLUNOMIDE
Arava
Arthritis
HWA486_6014NANCT00637819Summary
LEFLUNOMIDE
Arava
Arthritis
LEFLU_R_01143LEADEREudraCT: 2007-000886-40Summary Results
LEVOFLOXACIN
Tavanic
Pneumonia, Community-Acquired
HR355_3035HAPNCT00253955Summary
LEVOFLOXACIN
Tavanic
Infection
HR355_3036CBPNCT00277511Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted